Fortis Gurgaon
Targeted therapy in India typically costs from AUD $3,123 to AUD $7,808. Prices depend on the specific drug type, whether using branded or generic biologics, and if treatment is inpatient or daycare. In Australia, this treatment averages AUD $15,899, meaning patients can save approximately 65% by choosing Indian medical hubs like Delhi, Mumbai, or Chennai.
Bookimed Expert Insight: Significant value lies in India's status as a global hub for high-quality generic oncology drugs. Hospitals like BLK Super Speciality Hospital use diagnostic equipment identical to top European centres but at a fraction of the operating cost. Specialists such as Dr. Raj Nagarkar have performed over 50,000 surgeries, providing a level of clinical experience that is difficult to find elsewhere. This combination of high patient volumes and lower pharmaceutical costs offers Australians world-class care without the private health insurance gaps or waitlists found at home.
| India | Thailand | Turkey | |
| Targeted therapy | from AUD $3,123 | from AUD $9,937 | from AUD $1,420 |
| Oncothermia | from AUD $3,691 | from AUD $5,111 | from AUD $639 |
| Lutetium-177 therapy | from AUD $7,808 | from AUD $17,035 | from AUD $12,492 |
| Actinium-225 Therapy | from AUD $12,067 | from AUD $35,490 | from AUD $32,587 |
No hidden fees – just official clinic prices. Pay at the clinic for Targeted therapy upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Targeted therapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Targeted therapy journey.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
The doctor is a renowned specialist in high-risk pregnancy management with 35 years of experience in gynecology. Specializing in the management of complex cases such as ectopic pregnancies, the doctor is proficient in endoscopic operations, including laparoscopy and hysteroscopy. The doctor also focuses on the treatment of benign tumors, cysts, and the diagnosis and treatment of cervical and vaginal cancer. Additionally, the doctor performs various types of hysterectomies and palliative interventions for advanced cancer.
The doctor completed medical school in Gurgaon, followed by an internship in obstetrics-gynecology and subspecialization in endoscopic methods at the Fortis Memorial Research Institute. The doctor is a Senior Consultant at the Department of Obstetrics and Gynecology at the same institute and is an active member of several specialty societies.
The doctor is a highly skilled medical oncologist with a specialization in chemotherapy. With extensive experience in treating various types of cancer, the doctor employs advanced chemotherapy techniques to improve patient outcomes. The doctor stays at the forefront of oncological research, integrating the latest evidence-based practices into patient care. The doctor is recognized for contributions to clinical trials aimed at developing new cancer treatments, demonstrating a commitment to advancing the field of oncology.
The doctor received Surgical Oncology training at Tata Memorial Hospital, Mumbai, and completed MRCS at the Royal College of Surgeons, Edinburgh. Starting practice in 2000, the doctor founded Curie Manavata Cancer Centre in 2007. With 19 years of experience, the doctor has performed over 50,000 cancer surgeries and participated in more than 200 clinical trials. The doctor is a published author with numerous international and national publications. Specializing in Breast and Thoracic Surgical Oncology, the doctor is a professor for DNB Superspecialty Surgical Oncology and Breast Surgery at MUHS.
When considering Targeted therapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Lutetium-177 therapy is a targeted radiotherapy utilizing the Lutetium-177 radioisotope to treat certain cancers effectively.